This document provides an overview of pediatric anesthesiology. It discusses how children's anatomy and physiology differ from adults in ways that are important for anesthesia care. Key points include the large head size and airway structures in young children, differences in breathing, circulation, thermoregulation and pharmacokinetics compared to adults. Special considerations for prematurity, congenital conditions like Down syndrome and tetralogy of Fallot are also reviewed. The document concludes with a discussion of pediatric anesthesia on-call cases such as omphalocele and gastroschisis.
Hypothyroidism and hyperthyroidism have significant clinical effects. Both should be optimized. Anesthesia providers should be able to diagnose and manage.
In critical care medicine the invasive life saving techniques are often employed and when all goes well such interventions will be withdrawn to all for normal physiology to resume. Identifying this point for safe withdrawal for the resumption of normal respiratory function is of utmost importance.
Preoperative sedation and premedication in pediatrics Nida fatima
Sedation and premedication
Why? --Aims of premedication!
When?
How?
Drugs for premedication!
Routes for administration!
Side effects & complications!
Parental Anxiety
SEPARATION ANXIETY
Kids not small adults
Sedative -omitted for neonates and sick infants.
child's age, body weight, drug history, allergic status and medical or surgical conditions
Avoid needles!!
Oral premedication ≠ risk of aspiration pneumonia
Allay Anxiety & fear.
Reduce saliva and airway secretions.
Enhance the hypnotic effects of general anaesthesia.
Reduce postoperative nausea & vomiting.
Hypothyroidism and hyperthyroidism have significant clinical effects. Both should be optimized. Anesthesia providers should be able to diagnose and manage.
In critical care medicine the invasive life saving techniques are often employed and when all goes well such interventions will be withdrawn to all for normal physiology to resume. Identifying this point for safe withdrawal for the resumption of normal respiratory function is of utmost importance.
Preoperative sedation and premedication in pediatrics Nida fatima
Sedation and premedication
Why? --Aims of premedication!
When?
How?
Drugs for premedication!
Routes for administration!
Side effects & complications!
Parental Anxiety
SEPARATION ANXIETY
Kids not small adults
Sedative -omitted for neonates and sick infants.
child's age, body weight, drug history, allergic status and medical or surgical conditions
Avoid needles!!
Oral premedication ≠ risk of aspiration pneumonia
Allay Anxiety & fear.
Reduce saliva and airway secretions.
Enhance the hypnotic effects of general anaesthesia.
Reduce postoperative nausea & vomiting.
Anaesthesia challenges in neonatal emergencies-1.pptxsouravdash24
Neonatal emergencies present unique challenges in anesthesia, requiring specialized knowledge and skills to ensure safe and effective care for these vulnerable patients. This presentation delves into the intricacies of providing anesthesia to neonates in emergency situations, discussing physiological differences, equipment considerations, medication dosages, and monitoring techniques tailored to this population. Explore essential strategies and best practices for managing airway, ventilation, and hemodynamic stability in neonatal emergencies, aiming to optimize outcomes and mitigate risks. Whether you're a seasoned anesthesiologist or a healthcare professional seeking insight into neonatal anesthesia, this presentation offers valuable insights into navigating the complexities of neonatal emergencies with confidence and expertise.
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Pediatric anesthesiology board review
1. Pediatric Anesthesiology
James Gordon Cain, M.D.
Immediate Past President, International TraumaCare
Past President, West Virginia Society of Anesthesiologists
Director, Perioperative Medical Services, Children's Hospital of Pittsburgh of UPMC
Director, Trauma Anesthesiology, Children's Hospital of Pittsburgh of UPMC
Associate Professor, University of Pittsburgh
2. Pediatric Anesthesiology
● Children are not little adults!
– Neonates: 0-30 days old
– Infants: 1 month to 1 year
– Children: older than 1 year
● Special pediatric considerations
● Pediatric anesthesiology on call
● Malignant hyperthermia
3. Airway
● Head large
– 1/3 size of adult
head
– 1/9 height of adult
– 1/27 weight of
adult
● Tongue large
● Nasal passages
narrow
● Obligate nose
breathers until 5 mo
4. Airway
● Larynx
– Anterior
– Cephalad
– C 4 level
● Epiglottis long & U
shaped
● Trachea short
– Neonates → 2 cm
cords to carina
● Cricoid → Narrowest
point until 10 yo
5. Breathing
● Alveoli small & limited number
– Lung compliance decreased
● Cartilaginous rib cage
– Chest wall compliance increased
● Chest is circular shaped with horizontal ribs
● Diaphragm easily fatigued
– Fewer type 1 muscle cells
● Abdominal muscle strength undeveloped
● Airway resistance increased→ Poiseuille's Law
6. Breathing
● Low residual lung volumes at expiration (FRC)
– FRC overlaps closing capacity → atelectisis
● Hgb P50 19 mm Hg contrasts to 26 Hg adults
● Increased oxygen consumption → 7 ml/kg/min
– Higher minute ventilation
– Higher blood flow to vessel rich group
● Hypoxic/hypercapneic respiratory drives not
well developed
● Oxygen reserve is limited
7. Circulation
● Equalization of biventricular pressures
● Stroke volume fixed
● Cardiac output dependent upon heart rate
● Immature sympathetic and baroreceptor
response
– Lack of tachycardia to hypovolemia/hypotension
● Dysrhythmias
– Bradycardia
● Hypoxemia
8. Normal vital signs
Age Heart rate SBP Resp rate
Newborn 110-170 > 60 30-50
1 year 100-160 > 80 < 40
5 years 80-130 > 90 < 30
> 10 years < 90 > 90 < 20
11. Thermoregulation
● Greater heat loss
– Thin skin
– Low fat content
– High surface area/weight ratio
● No shivering until 1 yo
● Thermogenesis by brown fat
● More prone to iatragenic hypo/hyperthermia
12. Pharmacotherapy
● Weight “guesstimate” = 2 x (age) + 9
● Total body water content increased (70-75%)
– Large volume of distribution for water soluble
meds
– Increased dose/kg
● Hepatic biotransformation immature
● Protein binding decreased
● Neuromuscular junction immature
● Muscle mass in neonates smaller
– Termination of action by redistribution prolonged
13. Volatile anesthetics
● Minute ventilation to FRC ratio increased
● Blood flow to vessel rich groups increased.
– Rapid rise in alveolar anesthetic concentration
● Blood-gas coefficients lower in neonates
● Inhalation induction rapid
– BP of neonates and infants more sensitive to
hemodynamic effects of volatile agents
– Caution against overdose
15. IV/IM Anesthetics
● Ketamine mg/kg → 1-2 IV, 3-5 IM, 5-8 PO
● Benzodiazepines
– Midazolam mg/kg → 0.3-0.7 PO, 0.05-0.2 IV,
0.2-0.5 IN
● Propofol
– Larger doses/kg
– Propofol infusion syndrome
● Opioids
● Muscle relaxants
16. Propofol infusion syndrome
● Higher incidence in pediatrics than adults
● 90 mcg/kg/minute for as little as 8 hours
● Metabolic acidosis
● Hemodynamic instability
● Hepatomegaly
● Rhabdomyolosis
● Multiorgan failure
17. Opioids
● More potent in neonates than children or adults
– Easier across blood:brain barrier
– Decreased metabolic capability
– Increased sensitivity of respiratory centers
– Caution in neonates
● Hepatic conjugation decreased
● Cytochrome P 450 pathways mature by 1 mo
● Renal clearance of morphine metabolites is
decreased
● Children have high rates of hepatic blood flow
– Increased biotransformation and elimination
18. Neuromuscular blockers
● Shorter onset time (as much as 50%)
– Shorter circulation time
● Depolarizing agent
– Succinylcholine
● Nondepolarizing agents
– Rocuronium
– Cisatricurium
– Vecuronium
19. Succinylcholine
● Fastest onset → 30-60 secs
● Children → 1-1.5 mg/kg IV, 4-6 mg/kg IM
● Infants → 2-3 mg/kg IV, 4-6 mg/kg IM
● Dysrhythmias
– Bradycardia and sinus arrest
– Atropine 10-20 mcg/kg
● Hyperkalemia
● Masseter spasm
20. Nondepolarizing NMB
Rocuronium
● Drug of choice for
intubation
– 0.6 mg/kg IV
– RSI 0.9-1.2 mg/kg
IV
● May last 90
min
● May be given IM
– 1-1.5 mg /kg
● Onset 3-4 min
Cisatricurium
● Consistently
intermediate duration
● 0.05-0.06 mg/kg IV
21. ED 95 for muscle relaxants
(Rapid intubating dose is 1.5-2 x ED 95)
Agents Infants mg/kg Children mg/kg
Succinylcholine 0.7 0.4
Rocuronium 0.25 0.4
Cisatricurium 0.05 0.06
Vecuronium 0.05 0.08
23. Preoperative considerations
History and physical
● Comorbid illness
● Recent URI
● Murmur
– Innocent
– New
– Symptomatic
● Anesth problems
● Labs → none routine
NPO
● Clears → 2 h
● Breast milk → 4 h
● Formula → 6 h
● Solids → 8 h
Separation anxiety
● Anxiolysis
● Premeds
● Parental presence
24. URI
● Symptoms new or chronic?
– Infectious vs allergic or vasomotor
● Viral infection within 2 - 4 weeks of GA with
intubation increases perioperative risk
– Wheezing risk increased 10x
– Laryngospasm risk increased 5x
– Hypoxemia, atelectisis, recovery room stay,
admissions and ICU admissions all increased
● If possible, delay nonemergent surgeries
25. Monitoring
● Age & size appropriate standard monitors
● Precordial stethoscope
– Heart rate, heart tones, respiratory quality
● Preductal pulse oximetry in neonates
– Right extremity or earlobe
● EtCO2 monitor
– Main-stream less accurate in < 10 kg
– Side-stream may falsely elevate iCO2 and
falsely lower EtCO2.
● Temperature
26. Invasive monitoring
● Require expertise and
caution
● CVL most often IJ or
femoral
● A-line most often right
radial artery
– Preductal
● Mirrors carotid
& retinal
UA/UV may be
considered
28. Intraosseous
● IO kit or bone marrow bx
needle
● 1-2 cm below tibial tuberosity
● Insert with screwing motion
until lack of resistance
● Aspirate marrow to confirm
placement
● Secure needle
● Volume replacement
● Labs
● Drug administration
29. Airway management
● Mask
● LMA
● Intubation
– Neonate – 1 y
● 3 – 4 ETT
– Uncuffed ETT
● 4 + age/4
– Cuffed
● 3 ½ + age/4
– Depth
● 3 x tube size
● Blades
– Straight most
common
● Miller
● Phillips
● Wis-Hipple
– Curved available
– Fiberoptic
● Bullard
● Glide
30. Maintenance
● Balanced anesthetic most common
● Semiopen circuits circuits traditional
– Low resistance
– Light weight
– Mapleson D, Bain
● Circle systems with new machines
– VT 8-10 ml/kg
– PC/PS 15-18 cm H20
31. Perioperative fluid replacement
●
1st
0-10 kg → 4 cc/kg/hr
●
2nd
10-20 kg → 2 cc/kg/hr
● > 20 kg → 1 cc/kg/hr
● Calculate preoperative deficit
– Replace 50% first hour
– Replace 25% second hour
– Replace 25% third hour
● Minor surgery → additional 2 cc/kg/hr
● Major surgery → up to additional 10 cc/kg/hr
32. Estimated allowable blood loss
● Blood volume
– Premies → 95 ml/kg
– Term neonates → 90 ml/kg
– Up to 1 year → 80 ml/kg
– > 1 year old → 70 ml/kg
● EABL → wt kg x est blood vol x (starting Hct-
allowable Hct) / ave Hct
33. Blood product replacement
● Age appropriate Hct
– Premies and sick neonates Hct 40-50%
– Nadir at 3-6 months of 30%
● Comorbid conditions
● Replace initially with 3 x BSS or 1 x colloid
● Usual starting dose of PRBC is 10 cc/kg
● EBL ~ 1.5 blood volumes give FFP/platelets
– FFP 10 cc/kg
– Platelets 1 unit/10 kg raises platelets by 50K
– Cryo 1 U/10 kg
34. Laryngospasm
Etiology
● Involuntary spasm of
laryngeal musculature
– Superior laryngeal
nerve stimulation
● Risk inceased
– Extubated while
lightly
anesthetized
– Recent URI
– Tobacco exposure
Treatment
● Positive pressure
ventilation
● Laryngospasm notch
● Propofol
– 0.5–1 mg/kg IV
● Succinylcholine
– 0.2-0.5 mg/kg IV
– 2-4 mg/kg IM
35. Postintubation stridor
● Glottic or tracheal edema
● Associated with
– Large ETT
– Repeated intubation attempts
– Prolonged surgery
– ENT procedures
– Excessive tube movement
● Preventive dexamethasone
● Racemic epi neb
37. Regional
● Operative and postoperative utility
● Caudal is most common
● Options in adults available for children
– Peripheral blocks and catheters
● Epidural
– 0.2-0.3 cc/kg/hour covers ~ 4 dermatomes
– T wave changes may indicate toxicity
● Spinal
– Short duration even with tetracaine
38. Caudal
● Perioperative analgesia
– Ropivicaine 0.2% 1 cc/kg (up to 2 mg/kg)
– Bupivicaine 0.25% 1 cc/kg (up to 2.5 mg/kg)
– Opioids
● Duramorph 25-50 mcg/kg
● Hydromorphone 5-10 mcg/kg
– Clonidine 2 mcg/kg
● Minimal epidural fat
– May advance catheter to thoracic region
39. Prematurity
● Birth before 37 weeks gestation
– Pulmonary
● Hyaline membrane disease
● BPD
● Apneic spells
– 44 wks for minor surgery
– 52 wks for major surgery
– Cardiac → PDA
– GI → NEC
– Neurologic
● Intracerebral hemorrhage
● ROP
40. Trisomy 21: most common pattern
of human malformation
● Down's facies
● Short neck
● Irregular dentition
● Mental retardation
● Hypotonia
● Large tongue
● Narrow nasal passages
● Cervical spine → atlantooccipital instability
● Cardiac defects → endocardial cushion defects
41. Trisomy 21 anesthesia
● Difficult airway
● Postop intubation stridor and apnea common
● Neutral neck position
– Atlantooccipital dislocation risk
● Congenital laxity
● Bradydysrhythmias
– Atropine pretreatment
44. Pediatric anesthesia on call
● Omphalocele and
gastroschisis
● Congenital
diaphragmatic hernia
● Intestinal malrotation
and volvulus
● Pyloric stenosis
● Foreign body
ingestion/aspiration
45. Omphalocele and gastroschisis
Omphalocele
● Base of umbilicus
● Hernia sac
● Other assoc defects
– Trisomy 21
– Cardiac
– Diaphragmatic
hernia
– Bladder
malformation
Gastroschisis
● Lateral to umbilicus
● No hernia sac
● Not associated with
other defects
● Increased risk of
infection
46. Omphalocele and gastroschisis
● Decompress stomach
● Muscle relaxant to
assist reduction
● Criteria for closure
– Intragastric or
intravesical
pressure < 20
– PIP < 35
– EtCO2 < 50
● Silo possible
47. Congenital diaphragmatic hernia
● Gut herniates into chest
– Left (most common ~ 90%) or right
posterolateral foramen of Bochdalek
– Anterior foramen of Morgagni
● Hallmarks
– Hypoxia
– Scaphoid abdomen
– Bowel sounds in chest
● Respiratory support
● ECMO
48. Congenital diaphragmatic hernia
● NG tube
● Avoid high PPV
● Intubate
● PIP < 30
● Avoid aggressive lung
reexpansion
● Consider PTX if
sudden change in
compliance
49. Intestinal malrotation and volvulus
● Developmental abnormality
– 1:500 live births
● Spontaneous rotation of midgut around
mesentary (SMA)
● Presentation
– Acute or chronic obstruction
– Bilious vomiting
– Abdominal distention and tenderness
– Metabolic acidosis
50. Midgut volvulus
● True surgical
emergency
● Compromised
intestinal blood
supply
●
1/3 occur in 1st
week
of life
● Bloody diarrhea →
bowel infarction
51. Malro and volvulus anesthesia
● Obstruction present without obvious volvulus
– Stabilize coexisting conditions
– Insert NG
– Broad spectrum abx
– Fluid and electrolyte management
● To OR ASAP
● Cautious induction and anesthesia if unable to
be preoperatively stabilized
52. Malro and volvulus anesthesia
● Usually hypovolemic and acidemic
– Aggressive fluid management
– Consider bicarb
● Full stomach precautions
– RSI → ketamine?
– Awake intubation
● Opioid based anesthetic
● Post op intubation common
– Significant bowel edema → Silo
54. Pyloric stenosis
● 4-6 weeks old
● Male > female
● Persistent vomiting
● Metabolic disarray
– Hypochloremic metabolic alkalosis
● Vomiting depletes hydrogen ions
● Kidney compensates by excreting NaHCO3
● Hyponatremia and dehydration worsen
● Kidney conserves sodium at expense of
hydrogen → paradoxic aciduria
● Correct metabolic issues prior to surgery
55. Pyloric stenosis anesthesia
● Empty stomach
– Supine, lateral and prone
● RSI
– Propofol or thiopental + NMB or remi
● Awake intubation
● Laparoscopic vs open
● Post op
– Increased risk for respiratory depression
● Persistent metabolic or CSF alkalosis
56. Malignant hyperthermia
● Acute hypermetabolic state in muscle tissue
● Triggering agents
– Volatile agents
– Succinyl Choline
● Incidence
– 1:15,000 peds
– 1:40,000 adults
● MH may occur at any point during anesthesia
or emergence
● Recrudescence despite treatment
57. MH anesthesia
● Family history
– Muscle bx →
caffeine
contracture test
– +/- Ryanodine
receptor
abnormality
● High flow O2 flush
circuit x 20 min
● Nontriggering
– TIVA, Nitrous
Increased risk of MH
● Duchenne's muscular
dsytrophy
● Central core disease
● Osteogenesis
imperfecta
● King Denborough
syndrome
58. Classic signs of MH
Specific
● Rapid rise in EtCO2
early sign
● Rapid increase in
temp late sign
● Muscle rigidity +/-
● Rhabdomyolosis
– Increase CK
● Myoglobinuria
Nonspecific
● Tachycardia
● Tachypnea
● Acidemia
– Metabolic
– Respiratory
● Hyperkalemia
● Dysrhythmias
59. MH treatment
● Discontinue triggering agents
● Hyperventilate with 100% FiO2
● NaHCO3 1-2 mEq/kg IV
● Dantrolene 2.5 mg/kg IV
● Cool patient
● Support as indicated → intropes, dysrhythmias
● Monitor labs
● Consider invasive monitoring
● 1 800-MH-HYPER